Amado J. Zurita-Saavedra

Amado J. Zurita-Saavedra is a High Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on genitourinary cancers, particularly prostate and renal cell carcinoma, with specific interests in metastasis, pharmacology, radiation oncology, and the tumor microenvironment. His recent work includes developing multivariable prognostic models using KIM-1 and circulating tumor DNA for oligometastatic clear-cell renal cell carcinoma, investigating body composition’s influence on chemotherapy efficacy in aggressive variant prostate cancer, and exploring single-cell tumor microenvironment alterations as predictors of PD-1 blockade response. He leads multicenter trials, including the FORMULA-509 randomized trial of postprostatectomy salvage radiotherapy and the LenCabo phase II trial, with publications in European Urology, the Journal of Clinical Oncology, and Cancer Research.